Safe and effective heat therapy for the management of MGD
Heat
The use of heat is a well-established and important adjunct therapy in the management of meibomian gland dysfunction. As an Eye Care Professional your challenge is to deliver this therapy to your patients effectively and safely.
TearRestore Warm Compress gives you this reassurance.
TearRestore Warm Compress
TearRestore’s open-eye warm compress delivers an effective, user friendly at-home treatment for MGD. Developed with assistance from industry leading physicians, TearRestore delivers therapeutic heat where it is needed while allowing the patient to see throughout treatment.
TearRestore is the first open-eye warm compress that allows patients to be active during their treatment. The mask has specifically designed, reusable, heat packs that target the oil glands of the eyelid while avoiding the globes, permitting the user to blink throughout treatment resulting in natural oil gland expression.
Benefits of
TearRestore Warm Compress
Targeted treatment
It targets the Meibomian glands, resulting in natural oil gland expression throughout use.
Consistent Heat
Supplies therapeutic heat (>40C) for a minimum of ten minutes every use, ensuring effective treatment
Convenient
The only open-eye warm compress that allows patients to be active during treatment
+51%
Symptom improvement
+90%
Tear breakup time
* Reference data below
+40%
Increase in Functional
Meibomian Glands
Find out more about TearRestore
Our Downloads
TearRestore Brochure
PDF, 440MB
Full TearRestore Clinical data
PDF, 929KB
Circle of Care - Heat
PDF, 250MB
Interested in using TearRestore Warm Compress in your practice?
Contact us to find out more about TearRestore and to order.
Read the news on
Positive Impact
Dry Eye January: Empower your patients to take control of their eye health. Learn how to educate and engage your patients about the importance of early diagnosis and treatment for dry eye.
Positive Impact, in partnership with Visioneering Technologies, Inc. (VTI), has won The Contact Lens Award at the prestigious Optician Awards 2024 for its NaturalVue® Enhanced Multifocal 1 Day contact lens.
Join Nick Atkins in this CPD webinar as he explores effective heat delivery options for managing MGD. Gain insights into both in-practice and at-home solutions to enhance your practice’s MGD management strategies.
References
* Data was collected from a population of 22 eyes (age 18-89) of any race, gender or ethnicity, diagnosed with meibomian gland
dysfunction. Additional inclusion/exclusion criteria were applied. More information can be found at ClinicalTrials.gov